Qiagen NV | QIA - Equity Capital And Reserves

Stock Price
41.96
Daily Change
0.57 1.38%
Monthly
-6.16%
Yearly
13.93%
Q1 Forecast
40.37

Qiagen NV reported $3.78B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
argenx SE USD 6.1B 597.47M Jun/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Moderna USD 8.65B 680M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Qiagen NV USD 3.78B 128.73M Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025